Skip to main content

von Hippel-Lindau tumour suppressor

The VHL gene provides instructions for making a protein that functions as part of a complex (a group of proteins that work together) called the VCB-CUL2 complex. This complex targets other proteins to be broken down (degraded) by the cell when they are no longer needed. Protein degradation is a normal process that removes damaged or unnecessary proteins and helps maintain the normal functions of cells.

Video picks for Genes
Video library

Normal function

The VHL gene provides instructions for making a protein that functions as part of a complex (a group of proteins that work together) called the VCB-CUL2 complex. This complex targets other proteins to be broken down (degraded) by the cell when they are no longer needed. Protein degradation is a normal process that removes damaged or unnecessary proteins and helps maintain the normal functions of cells.

One of the targets of the VCB-CUL2 complex is a protein called hypoxia-inducible factor 2-alpha (HIF-2α). HIF-2α is one part (subunit) of a larger protein complex called HIF, which plays a critical role in the body's ability to adapt to changing oxygen levels. HIF controls several genes involved in cell division, the formation of new blood vessels, and the production of red blood cells. It is the major regulator of a hormone called erythropoietin, which controls red blood cell production. HIF's function is particularly important when oxygen levels are lower than normal (hypoxia). However, when adequate oxygen is available, the VCB-CUL2 complex keeps HIF from building up inappropriately in cells.

The VHL protein likely plays a role in other cellular functions, including the regulation of other genes and control of cell division. Based on this function, the VHL protein is classified as a tumour suppressor, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. The VHL protein is also involved in the formation of the extracellular matrix, which is an intricate lattice that forms in the spaces between cells and provides structural support to tissues.

Conditions referring to this gene or chromosome

Other names

pVHL

VHL1

VHL_HUMAN

Patient picks for Genes

Related patient information and medicines

Kidney cancer

Patient information leaflet

Kidney cancer

There are several types of kidney cancer but over 9 out of 10 kidney cancers are "renal cell cancer". This is sometimes called renal a... (A faulty gene which runs in some families may sometimes trigger kidney cancer. Also, people with some rare genetic disorders have a higher risk of developing kidney cancer - for example, von Hippel-Lindau.

Stomach cancer

Patient information leaflet

Stomach cancer

Most people who develop stomach cancer are over the age of 55. What are the types of stomach cancer. Adenocarcinoma of the stomach In most cases, stomach cancer begins from a cell ... For example, a blockage may be eased by removing part of the stomach, or by using laser surgery or by a bypass operation. Chemotherapy Chemotherapy is a treatment of.

Headache

Patient information leaflet

Headache

The most common types of headache are tension headaches and migraines. Treatment is with a course of steroids and they are typically needed for many months. Brain tumours Brain tumour Brain tumours is a very uncommon cause of headaches - although most patients with long-lasting, severe or persistent headaches start to worry that this may be the.

Primary liver cancer

Patient information leaflet

Primary liver cancer

Many people who develop primary liver cancer will already have symptoms associated with scarring of the liver (cirrhosis). If you already have cirrhosis and your health becomes worse quite quickly, the cause may be a liver cancer which has developed. Everyone with cirrhosis should be having regular monitoring with an ultrasound and blood tests to.

Acromegaly

Patient information leaflet

Acromegaly

This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth (tumour) in the pituitary gland. Treatment options include surgery to remove the growth and.

Cushing's syndrome

Patient information leaflet

Cushing's syndrome

Cushing's syndrome is caused by too high a level of glucocorticoid in the body. This can be caused by taking steroid medication long-term (the common cause) or by the body making too much cortisol (the main glucocorticoid made by the body). Symptoms usually develop gradually and so the diagnosis (other than that caused by steroid medication) may.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 8 May 2023 | Latest version
  • 1 Aug 2012 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.